Pain Managment: Part 1

Four experts on pain medicine answer readers’ questions on this ubiquitous area of general practice   Dr Marcia Schofield Senior Lecturer in Pain Management, CardiffDr Ashish Shetty Consultant in Pain Medicine, University College London HospitalsDr Michael Spencer Consultant Psychiatrist, Cambridge and LondonDr Rajesh Munglani Consultant in Pain Medicine, Cambridge and London Q What is the latest evidence on NSAIDS and risk of gastrointestinal adverse events?   A All non-selective NSAIDs increase the risk of gastrointestinal bleeding and ulcers. Celecoxib is gastroprotective in the short term. To prevent serious gastrointestinal complications, adding an anti-ulcer drug like misoprostol to non-selective NSAIDs or taking celecoxib are known to